Osteoporosis
New osteoporosis research from F. Borgstrom et al outlined
Published in Disease Risk Factor Week, March 28th, 2010
"Risedronate was found cost-effective from the age of 65 years, assuming a willingness to pay for a QALY of A 30,000 pound. The aim of this study was to assess the cost-effectiveness of risedronate for the prevention and treatment in a UK setting using the FRAXA ® algorithm for fracture risk assessment. A further aim was to establish intervention thresholds with risedronate treatment. The cost-effectiveness of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- Acromegaly Immunology
New acromegaly immunology study findings recently were reported by researchers at Clinical Center of Endocrinology - Alcohol and Alcoholism
Study data from G. Burazeri and co-authors update knowledge of alcohol and alcoholism - Allergies
Reports summarize allergy in adolescents study results from J.L. Lukrafka and co-researchers - Allergies
Research conducted at Ajou University has updated our knowledge about allergies - Allergies
Research from University of Kiel provides new data on allergies - Allergy Medicine
New allergy medicine research from Our Ladys Children's Hospital described - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
